News | May 03, 2024
Moderna posts Q1 2024 revenues at US$167 million
GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)
GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)
First-quarter 2024 revenues totaled $14.9 billion, a decrease of $3.6 billion, or 20%, compared to the prior-year quarter
The demand in Africa for COVID-19 vaccines has declined
Empowering Research, Enhancing Proficiency is the theme of this year’s Homoeopathic Symposium
First and only long-acting C5 complement inhibitor offers patients with AQP4 Ab+
The institution will be spread over an area of more than 8 acres
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
_256_384.jpg)
The Vice President also highlighted the importance of preventive healthcare and fitness
Subscribe To Our Newsletter & Stay Updated
